NasdaqCM - Nasdaq Real Time Price USD
Estrella Immunopharma, Inc. (ESLA)
1.0473
-0.0627
(-5.65%)
As of 1:12:03 PM EDT. Market Open.
Breakdown
TTM
6/30/2024
6/30/2023
6/30/2022
6/30/2021
Total Revenue
0
0
0
0
0
Operating Expense
8,816.3380
7,310.0980
11,114.4020
1,685.3470
733.6930
Operating Income
-8,816.3380
-7,310.0980
-11,114.4020
-1,685.3470
-733.6930
Pretax Income
-8,816.3380
-7,310.0980
-11,114.4020
-1,685.3470
-733.6930
Tax Provision
1.6250
1.6250
0
0
0
Net Income Common Stockholders
-8,817.9630
-7,311.7230
-11,114.4020
-1,685.3470
-733.6930
Diluted NI Available to Com Stockholders
-8,817.9630
-7,311.7230
-11,114.4020
-1,685.3470
-733.6930
Basic EPS
-0.24
-0.27
-0.32
-0.05
-0.02
Diluted EPS
-0.24
-0.27
-0.32
-0.05
-0.02
Basic Average Shares
36,190.8960
27,103.9640
35,201.2320
35,201.2320
35,201.2320
Diluted Average Shares
36,190.8960
27,103.9640
35,201.2320
35,201.2320
35,201.2320
Total Operating Income as Reported
-8,816.3380
-7,310.0980
-11,114.4020
-1,685.3470
-733.6930
Total Expenses
8,816.3380
7,310.0980
11,114.4020
1,685.3470
733.6930
Net Income from Continuing & Discontinued Operation
-8,817.9630
-7,311.7230
-11,114.4020
-1,685.3470
-733.6930
Normalized Income
-8,817.9630
-7,311.7230
-11,114.4020
-1,685.3470
-733.6930
EBIT
-8,816.3380
-7,310.0980
-11,114.4020
-1,685.3470
-733.6930
EBITDA
-8,816.3380
-7,310.0980
-11,114.4020
-1,685.3470
-733.6930
Net Income from Continuing Operation Net Minority Interest
-8,817.9630
-7,311.7230
-11,114.4020
-1,685.3470
-733.6930
Normalized EBITDA
-8,816.3380
-7,310.0980
-11,114.4020
-1,685.3470
-733.6930
Tax Rate for Calcs
0.0002
0.0002
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
6/30/2021 - 9/14/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
LIXTW Lixte Biotechnology Holdings, Inc.
0.0388
0.00%
APLMW Apollomics, Inc.
0.0085
-43.33%
1228.HK CANBRIDGE-B
0.135
-3.57%
TCBWF TC Biopharm (Holdings) Plc
0.0089
0.00%
2256.HK Abbisko Cayman Limited
7.830
+1.69%
DRMAW Dermata Therapeutics, Inc.
0.0249
0.00%
BETRF BetterLife Pharma Inc.
0.0700
-1.41%
COEPW Coeptis Therapeutics Holdings, Inc.
0.0251
+0.80%
WINTW WINDTREE THERAPEUTICS INC C/WTS
0.0070
+100.00%
PTIXW Protagenic Therapeutics, Inc.
0.0073
-1.33%